Portraits of TET-mediated DNA hydroxymethylation in cancer

The discovery of TET-mediated DNA hydroxymethylation as a mechanism of DNA demethylation, along with the observation of disrupted hydroxymethylation patterns in cancer, sparked high hopes of better understanding malignant processes. In this review, we discuss a plethora of recent studies that have s...

Full description

Saved in:
Bibliographic Details
Published in:Current opinion in genetics & development 2016-02, Vol.36, p.16-26
Main Authors: Jeschke, Jana, Collignon, Evelyne, Fuks, François
Format: Article
Language:English
Subjects:
5-Methylcytosine - metabolism
DNA Methylation - genetics
DNA-Binding Proteins - genetics
Epigenesis, Genetic
Gene Expression Regulation - genetics
Humans
Medical Education
Mixed Function Oxygenases - genetics
Neoplasms - genetics
Promoter Regions, Genetic
Proto-Oncogene Proteins - genetics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The discovery of TET-mediated DNA hydroxymethylation as a mechanism of DNA demethylation, along with the observation of disrupted hydroxymethylation patterns in cancer, sparked high hopes of better understanding malignant processes. In this review, we discuss a plethora of recent studies that have shed light on the mechanisms and biological consequences of DNA hydroxymethylation pattern changes in various cancers. A picture is taking shape, in which TET proteins appear as both promoters and suppressors of cancer. Their impairment at multiple levels creates abnormal 5hmC landscapes that affect, often in concert with key cancer pathways, a wider range of biological processes than initially proposed. As the picture gains in scope and precision, the prospect of 5hmC-pattern-targeting cancer therapies shimmers in the distance.
ISSN:0959-437X
1879-0380
DOI:10.1016/j.gde.2016.01.004